| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 3.27e-08 | 46 | 82 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.28e-07 | 12 | 82 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 TPR COL5A2 COL24A1 PCLO SNTG1 DLG2 SNTG2 DLG4 RPS23 PLP1 TNXB COL1A1 COL1A2 | 2.99e-06 | 891 | 82 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.23e-05 | 188 | 82 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | hepoxilin-epoxide hydrolase activity | 1.67e-05 | 2 | 82 | 2 | GO:0047977 | |
| GeneOntologyMolecularFunction | linoleate 13S-lipoxygenase activity | 4.98e-05 | 3 | 82 | 2 | GO:0016165 | |
| GeneOntologyMolecularFunction | arachidonate 15-lipoxygenase activity | 4.98e-05 | 3 | 82 | 2 | GO:0050473 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.21e-05 | 18 | 82 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 9.94e-05 | 4 | 82 | 2 | GO:0004052 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 1.65e-04 | 5 | 82 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.97e-04 | 70 | 82 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.03e-04 | 28 | 82 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.69e-04 | 37 | 82 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | carbonyl reductase (NADPH) activity | 5.89e-04 | 9 | 82 | 2 | GO:0004090 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 6.83e-04 | 42 | 82 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 8.94e-04 | 11 | 82 | 2 | GO:0004301 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 8.94e-04 | 11 | 82 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 9.21e-04 | 614 | 82 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 1.26e-03 | 13 | 82 | 2 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 1.26e-03 | 13 | 82 | 2 | GO:0016803 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.26e-03 | 13 | 82 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.42e-03 | 118 | 82 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.66e-03 | 123 | 82 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 1.93e-03 | 16 | 82 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.24e-03 | 441 | 82 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.91e-03 | 156 | 82 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 4.70e-03 | 25 | 82 | 2 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 5.08e-03 | 26 | 82 | 2 | GO:0016701 | |
| GeneOntologyMolecularFunction | SMAD binding | 5.35e-03 | 86 | 82 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 5.47e-03 | 27 | 82 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 5.88e-03 | 28 | 82 | 2 | GO:0005251 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 4.96e-07 | 76 | 80 | 6 | GO:0030199 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.53e-05 | 377 | 80 | 9 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.56e-05 | 378 | 80 | 9 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.59e-05 | 379 | 80 | 9 | GO:0045229 | |
| GeneOntologyBiologicalProcess | lipoxin A4 biosynthetic process | 4.45e-05 | 3 | 80 | 2 | GO:2001303 | |
| GeneOntologyBiologicalProcess | morphogenesis of an endothelium | 7.11e-05 | 21 | 80 | 3 | GO:0003159 | |
| GeneOntologyBiologicalProcess | endothelial tube morphogenesis | 7.11e-05 | 21 | 80 | 3 | GO:0061154 | |
| GeneOntologyBiologicalProcess | lipoxin A4 metabolic process | 8.87e-05 | 4 | 80 | 2 | GO:2001302 | |
| GeneOntologyBiologicalProcess | lipoxin biosynthetic process | 8.87e-05 | 4 | 80 | 2 | GO:2001301 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 9.92e-05 | 191 | 80 | 6 | GO:0006633 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | TKFC PSG6 UBR4 ANKRD23 MTHFS CBR1 PLP1 TNXB DCXR ALOX12 ALOX15 | 1.16e-04 | 731 | 80 | 11 | GO:0032787 |
| GeneOntologyBiologicalProcess | synaptic vesicle targeting | 1.47e-04 | 5 | 80 | 2 | GO:0016080 | |
| GeneOntologyBiologicalProcess | lipoxin metabolic process | 1.47e-04 | 5 | 80 | 2 | GO:2001300 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | TKFC PSG6 UBR4 NOXRED1 ANKRD23 MTHFS SUCLG2 CBR1 PLP1 TNXB DCXR ALOX12 ALOX15 | 1.64e-04 | 1035 | 80 | 13 | GO:0019752 |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 1.91e-04 | 29 | 80 | 3 | GO:0042759 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | TKFC PSG6 UBR4 NOXRED1 ANKRD23 MTHFS SUCLG2 CBR1 PLP1 TNXB DCXR ALOX12 ALOX15 | 2.03e-04 | 1058 | 80 | 13 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | TKFC PSG6 UBR4 NOXRED1 ANKRD23 MTHFS SUCLG2 CBR1 PLP1 TNXB DCXR ALOX12 ALOX15 | 2.15e-04 | 1064 | 80 | 13 | GO:0006082 |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 3.99e-04 | 89 | 80 | 4 | GO:2000379 | |
| GeneOntologyBiologicalProcess | hepoxilin metabolic process | 4.10e-04 | 8 | 80 | 2 | GO:0051121 | |
| GeneOntologyBiologicalProcess | hepoxilin biosynthetic process | 4.10e-04 | 8 | 80 | 2 | GO:0051122 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 4.16e-04 | 461 | 80 | 8 | GO:0006631 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.61e-10 | 12 | 80 | 5 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.61e-10 | 12 | 80 | 5 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.40e-08 | 21 | 80 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen trimer | 1.10e-06 | 88 | 80 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | dynein complex | 1.97e-06 | 54 | 80 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | collagen type I trimer | 1.45e-05 | 2 | 80 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | microtubule associated complex | 3.57e-05 | 161 | 80 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | syntrophin complex | 8.64e-05 | 4 | 80 | 2 | GO:0016013 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.17e-04 | 25 | 80 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.44e-04 | 5 | 80 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.82e-04 | 332 | 80 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 4.13e-04 | 91 | 80 | 4 | GO:0008076 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL2A1 COL3A1 COL5A2 FLNC DNAH3 DNAH10 DISC1 ANKRD23 DNAH9 DCXR KIF7 COL1A1 COL1A2 | 5.06e-04 | 1179 | 80 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL5A2 FLNC DNAH3 DNAH10 DISC1 ANKRD23 DNAH9 DCXR KIF7 COL1A1 COL1A2 | 5.39e-04 | 1187 | 80 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | inner dynein arm | 6.38e-04 | 10 | 80 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | potassium channel complex | 6.84e-04 | 104 | 80 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.90e-04 | 656 | 80 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 9.09e-04 | 658 | 80 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 9.31e-04 | 12 | 80 | 2 | GO:0044224 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 9.48e-04 | 530 | 80 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.43e-03 | 320 | 80 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | cation channel complex | 2.09e-03 | 235 | 80 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.37e-03 | 354 | 80 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.58e-03 | 360 | 80 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 2.63e-03 | 20 | 80 | 2 | GO:0016010 | |
| GeneOntologyCellularComponent | basal part of cell | 3.28e-03 | 378 | 80 | 6 | GO:0045178 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.28e-03 | 378 | 80 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.88e-03 | 523 | 80 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | glycoprotein complex | 4.10e-03 | 25 | 80 | 2 | GO:0090665 | |
| GeneOntologyCellularComponent | transporter complex | 5.10e-03 | 550 | 80 | 7 | GO:1990351 | |
| HumanPheno | Atrophic scars | 6.21e-08 | 37 | 31 | 6 | HP:0001075 | |
| HumanPheno | Arterial rupture | 7.73e-08 | 8 | 31 | 4 | HP:0025019 | |
| HumanPheno | Dermal atrophy | 1.54e-07 | 107 | 31 | 8 | HP:0004334 | |
| HumanPheno | Cervical insufficiency | 8.13e-07 | 4 | 31 | 3 | HP:0030009 | |
| HumanPheno | Fragile skin | 2.26e-06 | 37 | 31 | 5 | HP:0001030 | |
| HumanPheno | Atypical scarring of skin | 4.23e-06 | 74 | 31 | 6 | HP:0000987 | |
| HumanPheno | Soft skin | 5.48e-06 | 44 | 31 | 5 | HP:0000977 | |
| HumanPheno | Molluscoid pseudotumors | 7.03e-06 | 7 | 31 | 3 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 7.03e-06 | 7 | 31 | 3 | HP:0000139 | |
| HumanPheno | Genital hernia | 1.12e-05 | 8 | 31 | 3 | HP:0100823 | |
| HumanPheno | Poor wound healing | 1.27e-05 | 52 | 31 | 5 | HP:0001058 | |
| HumanPheno | Abnormal heart valve morphology | COL2A1 COL3A1 COL5A2 FLNC RTEL1 MMP21 DNAH9 TNXB HNRNPK LUZP1 KIF7 COL1A1 COL1A2 | 1.62e-05 | 588 | 31 | 13 | HP:0001654 |
| HumanPheno | Aplasia/Hypoplasia of the skin | 1.84e-05 | 201 | 31 | 8 | HP:0008065 | |
| HumanPheno | Abnormal mitral valve morphology | 2.03e-05 | 146 | 31 | 7 | HP:0031477 | |
| HumanPheno | Cigarette-paper scars | 2.38e-05 | 10 | 31 | 3 | HP:0001073 | |
| HumanPheno | Scarring | 2.73e-05 | 102 | 31 | 6 | HP:0100699 | |
| HumanPheno | Joint subluxation | 3.15e-05 | 31 | 31 | 4 | HP:0032153 | |
| HumanPheno | Biconcave flattened vertebrae | 3.58e-05 | 2 | 31 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 3.58e-05 | 2 | 31 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 3.58e-05 | 2 | 31 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 3.58e-05 | 2 | 31 | 2 | HP:0005005 | |
| HumanPheno | Arterial dissection | 4.33e-05 | 12 | 31 | 3 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 4.33e-05 | 12 | 31 | 3 | HP:0004947 | |
| HumanPheno | Aortic root aneurysm | 5.46e-05 | 70 | 31 | 5 | HP:0002616 | |
| HumanPheno | Abnormal uterine cervix morphology | 5.60e-05 | 13 | 31 | 3 | HP:0012888 | |
| HumanPheno | Bladder diverticulum | 5.77e-05 | 36 | 31 | 4 | HP:0000015 | |
| HumanPheno | Abnormal elasticity of skin | 6.25e-05 | 238 | 31 | 8 | HP:0010647 | |
| HumanPheno | Recurrent joint dislocation | 7.10e-05 | 14 | 31 | 3 | HP:0031869 | |
| HumanPheno | Neonatal short-limb short stature | 7.10e-05 | 14 | 31 | 3 | HP:0008921 | |
| HumanPheno | Soft, doughy skin | 7.10e-05 | 14 | 31 | 3 | HP:0001027 | |
| HumanPheno | Hiatus hernia | 7.17e-05 | 38 | 31 | 4 | HP:0002036 | |
| HumanPheno | Striae distensae | 7.17e-05 | 38 | 31 | 4 | HP:0001065 | |
| HumanPheno | Thoracic aortic aneurysm | 7.18e-05 | 121 | 31 | 6 | HP:0012727 | |
| HumanPheno | Abnormally lax or hyperextensible skin | 7.57e-05 | 179 | 31 | 7 | HP:0008067 | |
| HumanPheno | Localized skin lesion | COL2A1 COL3A1 COL5A2 TRPM4 RTEL1 SBF2 C1R DLG4 PLP1 TNXB HNRNPK LUZP1 KIF7 COL1A1 COL1A2 | 7.83e-05 | 897 | 31 | 15 | HP:0011355 |
| HumanPheno | Mitral valve prolapse | 7.87e-05 | 123 | 31 | 6 | HP:0001634 | |
| HumanPheno | Abdominal aortic aneurysm | 8.62e-05 | 125 | 31 | 6 | HP:0005112 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 1.07e-04 | 3 | 31 | 2 | HP:0006201 | |
| HumanPheno | Popcorn calcification | 1.07e-04 | 3 | 31 | 2 | HP:6000871 | |
| HumanPheno | Subcutaneous spheroids | 1.07e-04 | 3 | 31 | 2 | HP:0025014 | |
| HumanPheno | Abnormal mitral valve morphology | 1.08e-04 | 257 | 31 | 8 | HP:0001633 | |
| HumanPheno | Premature rupture of membranes | 1.31e-04 | 17 | 31 | 3 | HP:0001788 | |
| HumanPheno | Dilatation of the ascending aorta | 1.31e-04 | 84 | 31 | 5 | HP:0005111 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 1.60e-04 | 350 | 31 | 9 | HP:0006705 | |
| HumanPheno | Generalized joint hypermobility | 1.81e-04 | 48 | 31 | 4 | HP:0002761 | |
| HumanPheno | Thin skin | 1.82e-04 | 90 | 31 | 5 | HP:0000963 | |
| HumanPheno | Short limb dwarfism | 1.85e-04 | 19 | 31 | 3 | HP:0003505 | |
| HumanPheno | Abnormal delivery | 1.96e-04 | 145 | 31 | 6 | HP:0001787 | |
| HumanPheno | Piezogenic pedal papules | 2.13e-04 | 4 | 31 | 2 | HP:0025509 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 2.13e-04 | 4 | 31 | 2 | HP:0003023 | |
| HumanPheno | Incisional hernia | 2.13e-04 | 4 | 31 | 2 | HP:0004872 | |
| HumanPheno | Shoulder dislocation | 2.17e-04 | 20 | 31 | 3 | HP:0003834 | |
| HumanPheno | Generalized osteoporosis | 2.17e-04 | 20 | 31 | 3 | HP:0040160 | |
| HumanPheno | Pes planus | 2.21e-04 | 365 | 31 | 9 | HP:0001763 | |
| HumanPheno | Dwarfism | 2.52e-04 | 21 | 31 | 3 | HP:0001516 | |
| HumanPheno | Joint laxity | 3.08e-04 | 55 | 31 | 4 | HP:0001388 | |
| HumanPheno | Abnormality of hand joint mobility | 3.54e-04 | 57 | 31 | 4 | HP:0006256 | |
| HumanPheno | Hypermobility of interphalangeal joints | 3.54e-04 | 5 | 31 | 2 | HP:0005620 | |
| HumanPheno | Basilar impression | 3.54e-04 | 5 | 31 | 2 | HP:0005758 | |
| HumanPheno | Interrupted inferior vena cava with azygous continuation | 3.54e-04 | 5 | 31 | 2 | HP:0011671 | |
| HumanPheno | Hyperextensible skin | 3.59e-04 | 162 | 31 | 6 | HP:0000974 | |
| HumanPheno | Long fingers | 3.61e-04 | 306 | 31 | 8 | HP:0100807 | |
| HumanPheno | Blue sclerae | 4.27e-04 | 108 | 31 | 5 | HP:0000592 | |
| HumanPheno | Biconcave vertebral bodies | 4.29e-04 | 25 | 31 | 3 | HP:0004586 | |
| HumanPheno | Aortic dilatation | 4.36e-04 | 168 | 31 | 6 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 4.36e-04 | 168 | 31 | 6 | HP:0004942 | |
| HumanPheno | Lack of skin elasticity | 4.60e-04 | 61 | 31 | 4 | HP:0100679 | |
| HumanPheno | Crumpled long bones | 5.30e-04 | 6 | 31 | 2 | HP:0006367 | |
| HumanPheno | Pulmonic regurgitation | 5.41e-04 | 27 | 31 | 3 | HP:0010444 | |
| HumanPheno | Dermal translucency | 5.41e-04 | 27 | 31 | 3 | HP:0010648 | |
| HumanPheno | Hip dysplasia | 5.59e-04 | 247 | 31 | 7 | HP:0001385 | |
| HumanPheno | Abnormal tricuspid valve morphology | 5.71e-04 | 115 | 31 | 5 | HP:0001702 | |
| HumanPheno | Premature birth | 5.77e-04 | 177 | 31 | 6 | HP:0001622 | |
| HumanPheno | Osteoarthritis | 5.87e-04 | 65 | 31 | 4 | HP:0002758 | |
| HumanPheno | Bruising susceptibility | 5.94e-04 | 178 | 31 | 6 | HP:0000978 | |
| HumanPheno | Left anterior fascicular block | 7.39e-04 | 7 | 31 | 2 | HP:0011711 | |
| HumanPheno | Pulp calcification | 7.39e-04 | 7 | 31 | 2 | HP:0003771 | |
| HumanPheno | Myelin outfoldings | 7.39e-04 | 7 | 31 | 2 | HP:0004336 | |
| HumanPheno | Otosclerosis | 7.39e-04 | 7 | 31 | 2 | HP:0000362 | |
| HumanPheno | Phalangeal dislocation | 7.39e-04 | 7 | 31 | 2 | HP:0006243 | |
| HumanPheno | Gingival recession | 7.39e-04 | 7 | 31 | 2 | HP:0030816 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 7.41e-04 | 30 | 31 | 3 | HP:0005743 | |
| HumanPheno | Blepharochalasis | 9.81e-04 | 8 | 31 | 2 | HP:0010749 | |
| HumanPheno | Bell-shaped thorax | 9.84e-04 | 33 | 31 | 3 | HP:0001591 | |
| HumanPheno | Abnormal aortic morphology | 1.13e-03 | 363 | 31 | 8 | HP:0030963 | |
| HumanPheno | Abnormality of dental structure | 1.24e-03 | 368 | 31 | 8 | HP:0011061 | |
| HumanPheno | Peripheral hypermyelination | 1.26e-03 | 9 | 31 | 2 | HP:0030173 | |
| HumanPheno | Acrocyanosis | 1.27e-03 | 36 | 31 | 3 | HP:0001063 | |
| HumanPheno | Arthralgia | 1.31e-03 | 207 | 31 | 6 | HP:0002829 | |
| HumanPheno | Periodontitis | 1.38e-03 | 37 | 31 | 3 | HP:0000704 | |
| HumanPheno | Retrognathia | 1.40e-03 | 375 | 31 | 8 | HP:0000278 | |
| HumanPheno | Abnormality of primary teeth | 1.41e-03 | 82 | 31 | 4 | HP:0006481 | |
| HumanPheno | Abnormal sclera morphology | 1.44e-03 | 141 | 31 | 5 | HP:0000591 | |
| HumanPheno | Peripheral cyanosis | 1.49e-03 | 38 | 31 | 3 | HP:0034033 | |
| HumanPheno | Vascular dilatation | 1.60e-03 | 215 | 31 | 6 | HP:0002617 | |
| HumanPheno | Decreased skull ossification | 1.61e-03 | 39 | 31 | 3 | HP:0004331 | |
| HumanPheno | Abnormal knee physiology | 1.76e-03 | 87 | 31 | 4 | HP:0034670 | |
| HumanPheno | Abnormal epiphyseal ossification | 1.83e-03 | 88 | 31 | 4 | HP:0010656 | |
| HumanPheno | Disproportionate tall stature | 1.86e-03 | 41 | 31 | 3 | HP:0001519 | |
| HumanPheno | Tibial bowing | 1.86e-03 | 41 | 31 | 3 | HP:0002982 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 6.89e-06 | 27 | 65 | 4 | MP:0008438 | |
| Domain | Fib_collagen_C | 2.50e-12 | 11 | 81 | 6 | IPR000885 | |
| Domain | COLFI | 2.50e-12 | 11 | 81 | 6 | PF01410 | |
| Domain | NC1_FIB | 2.50e-12 | 11 | 81 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 2.50e-12 | 11 | 81 | 6 | PD002078 | |
| Domain | COLFI | 2.50e-12 | 11 | 81 | 6 | SM00038 | |
| Domain | Collagen | 1.84e-06 | 85 | 81 | 6 | IPR008160 | |
| Domain | Collagen | 1.84e-06 | 85 | 81 | 6 | PF01391 | |
| Domain | PDZ | 4.14e-06 | 151 | 81 | 7 | PS50106 | |
| Domain | PDZ | 4.32e-06 | 152 | 81 | 7 | IPR001478 | |
| Domain | VWC | 6.21e-06 | 28 | 81 | 4 | PF00093 | |
| Domain | VWFC_1 | 1.74e-05 | 36 | 81 | 4 | PS01208 | |
| Domain | VWC | 2.17e-05 | 38 | 81 | 4 | SM00214 | |
| Domain | VWFC_2 | 2.17e-05 | 38 | 81 | 4 | PS50184 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.76e-05 | 14 | 81 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.76e-05 | 14 | 81 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.76e-05 | 14 | 81 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.76e-05 | 14 | 81 | 3 | PF08393 | |
| Domain | MT | 2.76e-05 | 14 | 81 | 3 | PF12777 | |
| Domain | AAA_8 | 2.76e-05 | 14 | 81 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.76e-05 | 14 | 81 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.76e-05 | 14 | 81 | 3 | PF07728 | |
| Domain | VWF_dom | 3.24e-05 | 42 | 81 | 4 | IPR001007 | |
| Domain | PDZ | 3.39e-05 | 141 | 81 | 6 | PF00595 | |
| Domain | DHC_fam | 3.44e-05 | 15 | 81 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.44e-05 | 15 | 81 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 3.44e-05 | 15 | 81 | 3 | PF03028 | |
| Domain | PDZ | 4.45e-05 | 148 | 81 | 6 | SM00228 | |
| Domain | - | 4.80e-05 | 150 | 81 | 6 | 2.30.42.10 | |
| Domain | Protein_Kinase_C_mu-related | 5.56e-05 | 3 | 81 | 2 | IPR015727 | |
| Domain | SBF2 | 5.56e-05 | 3 | 81 | 2 | PF12335 | |
| Domain | SBF1/SBF2 | 5.56e-05 | 3 | 81 | 2 | IPR022096 | |
| Domain | MAGUK_N_PEST | 1.11e-04 | 4 | 81 | 2 | PF10608 | |
| Domain | PDZ_assoc | 1.11e-04 | 4 | 81 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 1.11e-04 | 4 | 81 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 1.11e-04 | 4 | 81 | 2 | IPR019583 | |
| Domain | MAGUK_N_PEST | 1.11e-04 | 4 | 81 | 2 | SM01277 | |
| Domain | DLG1 | 1.11e-04 | 4 | 81 | 2 | IPR016313 | |
| Domain | Syntrophin | 1.84e-04 | 5 | 81 | 2 | IPR015482 | |
| Domain | PH | 2.04e-04 | 278 | 81 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 2.09e-04 | 279 | 81 | 7 | PS50003 | |
| Domain | PH_domain | 2.13e-04 | 280 | 81 | 7 | IPR001849 | |
| Domain | Prefoldin | 2.70e-04 | 72 | 81 | 4 | IPR009053 | |
| Domain | LipOase_mml | 2.76e-04 | 6 | 81 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 2.76e-04 | 6 | 81 | 2 | PS00711 | |
| Domain | LipOase_C | 2.76e-04 | 6 | 81 | 2 | IPR013819 | |
| Domain | Lipoxygenase | 2.76e-04 | 6 | 81 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 2.76e-04 | 6 | 81 | 2 | PS51393 | |
| Domain | LIPOXYGENASE_2 | 2.76e-04 | 6 | 81 | 2 | PS00081 | |
| Domain | LipOase | 2.76e-04 | 6 | 81 | 2 | IPR000907 | |
| Domain | LipOase_Fe_BS | 2.76e-04 | 6 | 81 | 2 | IPR020833 | |
| Domain | LipOase_CS | 2.76e-04 | 6 | 81 | 2 | IPR020834 | |
| Domain | DHC_N1 | 5.11e-04 | 8 | 81 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 5.11e-04 | 8 | 81 | 2 | IPR013594 | |
| Domain | P-loop_NTPase | DNAH3 DNAH10 RTEL1 MTG2 RAD54B DLG2 DLG4 DDX43 DNAH9 ABCA8 KIF7 | 1.05e-03 | 848 | 81 | 11 | IPR027417 |
| Domain | - | 1.41e-03 | 746 | 81 | 10 | 3.40.50.300 | |
| Domain | Ion_trans_dom | 1.53e-03 | 114 | 81 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.53e-03 | 114 | 81 | 4 | PF00520 | |
| Domain | Myotubularin-like_Pase_dom | 1.63e-03 | 14 | 81 | 2 | IPR010569 | |
| Domain | uDENN | 1.63e-03 | 14 | 81 | 2 | SM00800 | |
| Domain | PPASE_MYOTUBULARIN | 1.63e-03 | 14 | 81 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 1.63e-03 | 14 | 81 | 2 | IPR030564 | |
| Domain | Myotub-related | 1.63e-03 | 14 | 81 | 2 | PF06602 | |
| Domain | uDENN | 1.88e-03 | 15 | 81 | 2 | PF03456 | |
| Domain | UDENN | 2.14e-03 | 16 | 81 | 2 | PS50946 | |
| Domain | DDENN | 2.14e-03 | 16 | 81 | 2 | PS50947 | |
| Domain | GRAM | 2.14e-03 | 16 | 81 | 2 | SM00568 | |
| Domain | DENN | 2.14e-03 | 16 | 81 | 2 | SM00799 | |
| Domain | Guanylate_kinase_CS | 2.14e-03 | 16 | 81 | 2 | IPR020590 | |
| Domain | dDENN | 2.14e-03 | 16 | 81 | 2 | SM00801 | |
| Domain | DENN | 2.14e-03 | 16 | 81 | 2 | PF02141 | |
| Domain | dDENN_dom | 2.14e-03 | 16 | 81 | 2 | IPR005112 | |
| Domain | uDENN_dom | 2.14e-03 | 16 | 81 | 2 | IPR005113 | |
| Domain | dDENN | 2.14e-03 | 16 | 81 | 2 | PF03455 | |
| Domain | DENN | 2.14e-03 | 16 | 81 | 2 | PS50211 | |
| Domain | DENN_dom | 2.14e-03 | 16 | 81 | 2 | IPR001194 | |
| Domain | PH_dom-like | 2.49e-03 | 426 | 81 | 7 | IPR011993 | |
| Domain | LH2 | 2.72e-03 | 18 | 81 | 2 | SM00308 | |
| Domain | PH | 3.19e-03 | 229 | 81 | 5 | PF00169 | |
| Domain | AAA+_ATPase | 3.56e-03 | 144 | 81 | 4 | IPR003593 | |
| Domain | AAA | 3.56e-03 | 144 | 81 | 4 | SM00382 | |
| Domain | PLAT | 3.70e-03 | 21 | 81 | 2 | PS50095 | |
| Domain | DAG/PE-bd | 3.70e-03 | 21 | 81 | 2 | IPR020454 | |
| Domain | - | 3.70e-03 | 21 | 81 | 2 | 2.60.60.20 | |
| Domain | PLAT | 3.70e-03 | 21 | 81 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 3.70e-03 | 21 | 81 | 2 | IPR001024 | |
| Domain | GRAM | 4.06e-03 | 22 | 81 | 2 | PF02893 | |
| Domain | GRAM | 4.06e-03 | 22 | 81 | 2 | IPR004182 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.98e-09 | 30 | 67 | 6 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.54e-09 | 32 | 67 | 6 | MM14924 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.30e-08 | 19 | 67 | 5 | MM15512 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.62e-08 | 41 | 67 | 6 | M27778 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.62e-08 | 44 | 67 | 6 | M27812 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.45e-08 | 47 | 67 | 6 | MM14925 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.71e-07 | 30 | 67 | 5 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.39e-07 | 59 | 67 | 6 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.15e-07 | 61 | 67 | 6 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 7.29e-07 | 67 | 67 | 6 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.37e-06 | 41 | 67 | 5 | MM15538 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.54e-06 | 76 | 67 | 6 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.94e-06 | 79 | 67 | 6 | M27643 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.46e-06 | 46 | 67 | 5 | M198 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.79e-06 | 84 | 67 | 6 | M7098 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.74e-06 | 50 | 67 | 5 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.18e-06 | 90 | 67 | 6 | M631 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.01e-06 | 53 | 67 | 5 | MM14566 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 7.53e-06 | 27 | 67 | 4 | M27217 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.01e-05 | 61 | 67 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.28e-05 | 64 | 67 | 5 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.49e-05 | 66 | 67 | 5 | M18 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.60e-05 | 67 | 67 | 5 | MM15345 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.61e-05 | 74 | 67 | 5 | M160 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.90e-05 | 258 | 67 | 8 | MM14572 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.97e-05 | 76 | 67 | 5 | MM14867 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.97e-05 | 76 | 67 | 5 | MM14573 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.27e-05 | 199 | 67 | 7 | M7253 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 5.00e-05 | 43 | 67 | 4 | M39565 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.10e-05 | 85 | 67 | 5 | M16441 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 7.96e-05 | 18 | 67 | 3 | M22001 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.40e-05 | 300 | 67 | 8 | M610 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 9.10e-05 | 50 | 67 | 4 | M48087 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 9.42e-05 | 19 | 67 | 3 | M27221 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.10e-04 | 20 | 67 | 3 | MM15061 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 1.70e-04 | 23 | 67 | 3 | M39382 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 FGF23 COL5A2 COL24A1 ATP6V0A1 DLG4 ADCYAP1 COL1A1 COL1A2 | 1.93e-04 | 532 | 67 | 10 | M27870 |
| Pathway | WP_OXYLIPINS_PATHWAYS | 1.93e-04 | 24 | 67 | 3 | MM17249 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.05e-04 | 114 | 67 | 5 | MM14571 | |
| Pathway | WP_FOCAL_ADHESION | 2.56e-04 | 187 | 67 | 6 | MM15913 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.77e-04 | 27 | 67 | 3 | M47755 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 3.09e-04 | 28 | 67 | 3 | MM15957 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.09e-04 | 28 | 67 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.09e-04 | 28 | 67 | 3 | M27241 | |
| Pathway | WP_METABOLISM_OF_ALPHALINOLENIC_ACID | 3.30e-04 | 6 | 67 | 2 | M39844 | |
| Pathway | WP_FOCAL_ADHESION | 3.58e-04 | 199 | 67 | 6 | M39402 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.80e-04 | 30 | 67 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.80e-04 | 30 | 67 | 3 | MM15812 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 4.60e-04 | 7 | 67 | 2 | M48265 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 4.60e-04 | 7 | 67 | 2 | M27139 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 4.60e-04 | 7 | 67 | 2 | MM14860 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.30e-04 | 140 | 67 | 5 | M587 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.59e-04 | 302 | 67 | 7 | M39719 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 6.12e-04 | 8 | 67 | 2 | M48236 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.69e-04 | 38 | 67 | 3 | MM14969 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.78e-04 | 326 | 67 | 7 | MM15917 | |
| Pathway | KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX | 9.77e-04 | 10 | 67 | 2 | M47575 | |
| Pathway | WP_OSTEOBLAST_SIGNALING | 9.77e-04 | 10 | 67 | 2 | MM15862 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.03e-03 | 42 | 67 | 3 | M7169 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.11e-03 | 43 | 67 | 3 | M47669 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.25e-03 | 99 | 67 | 4 | MM14910 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.26e-03 | 45 | 67 | 3 | M47670 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.42e-03 | 12 | 67 | 2 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.42e-03 | 12 | 67 | 2 | M27352 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.42e-03 | 12 | 67 | 2 | MM15452 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.48e-03 | 176 | 67 | 5 | MM15718 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.61e-03 | 106 | 67 | 4 | M27200 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.76e-03 | 183 | 67 | 5 | M997 | |
| Pathway | WP_OSTEOBLAST_SIGNALING | 1.95e-03 | 14 | 67 | 2 | M39599 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.25e-03 | 15 | 67 | 2 | M27161 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47816 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.50e-03 | 57 | 67 | 3 | MM14713 | |
| Pathway | WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE | 2.50e-03 | 57 | 67 | 3 | M48332 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 2.56e-03 | 16 | 67 | 2 | M9450 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 2.63e-03 | 58 | 67 | 3 | M5410 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.63e-03 | 58 | 67 | 3 | M2049 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.76e-03 | 59 | 67 | 3 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.03e-03 | 61 | 67 | 3 | MM14861 | |
| Pathway | WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY | 3.24e-03 | 18 | 67 | 2 | M39586 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.24e-03 | 18 | 67 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.24e-03 | 18 | 67 | 2 | MM14882 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 3.24e-03 | 18 | 67 | 2 | M39421 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.32e-03 | 63 | 67 | 3 | M11187 | |
| Pathway | PID_IL4_2PATHWAY | 3.48e-03 | 64 | 67 | 3 | M28 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.60e-03 | 418 | 67 | 7 | MM15587 | |
| Pathway | REACTOME_PROTEIN_HYDROXYLATION | 3.61e-03 | 19 | 67 | 2 | MM17069 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 3.61e-03 | 19 | 67 | 2 | M48230 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 3.61e-03 | 19 | 67 | 2 | M27889 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.87e-03 | 135 | 67 | 4 | MM14781 | |
| Pathway | REACTOME_PROTEIN_HYDROXYLATION | 4.00e-03 | 20 | 67 | 2 | M48009 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 4.00e-03 | 20 | 67 | 2 | M17670 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 4.30e-03 | 69 | 67 | 3 | M48052 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.41e-03 | 21 | 67 | 2 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 4.41e-03 | 21 | 67 | 2 | M27944 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 4.83e-03 | 22 | 67 | 2 | MM15961 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.83e-03 | 22 | 67 | 2 | MM15104 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 4.83e-03 | 22 | 67 | 2 | MM15614 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 5.28e-03 | 23 | 67 | 2 | M27949 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.39e-03 | 339 | 67 | 6 | M39736 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 6.22e-03 | 25 | 67 | 2 | M274 | |
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 1.50e-10 | 5 | 83 | 4 | 9659900 | |
| Pubmed | 4.51e-10 | 6 | 83 | 4 | 15514164 | ||
| Pubmed | 4.51e-10 | 6 | 83 | 4 | 9101290 | ||
| Pubmed | 2.10e-09 | 8 | 83 | 4 | 18816857 | ||
| Pubmed | 3.51e-09 | 25 | 83 | 5 | 19180518 | ||
| Pubmed | 3.76e-09 | 9 | 83 | 4 | 8900172 | ||
| Pubmed | 6.26e-09 | 10 | 83 | 4 | 14559231 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 23546968 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 34205850 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 1.31e-08 | 3 | 83 | 3 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 1.31e-08 | 3 | 83 | 3 | 1879336 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 12200454 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 21044884 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 17662583 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 1.31e-08 | 3 | 83 | 3 | 24088220 | |
| Pubmed | Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. | 1.31e-08 | 3 | 83 | 3 | 1297453 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 1.31e-08 | 3 | 83 | 3 | 2010058 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 2.44e-08 | 36 | 83 | 5 | 26053890 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.69e-08 | 135 | 83 | 7 | 28675934 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 4.03e-08 | 15 | 83 | 4 | 9832566 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 30292394 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 12874293 | ||
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 5.23e-08 | 4 | 83 | 3 | 8984825 | |
| Pubmed | Immunohistochemical characteristics of developing mandibular angle in fetal mice. | 5.23e-08 | 4 | 83 | 3 | 16356873 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 9880238 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 10633870 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 19932771 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 24361166 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 1409674 | ||
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 5.23e-08 | 4 | 83 | 3 | 2054384 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 8686743 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 16537906 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 11175280 | ||
| Pubmed | 5.37e-08 | 16 | 83 | 4 | 17881772 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 6.21e-08 | 86 | 83 | 6 | 28327460 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.28e-07 | 97 | 83 | 6 | 27559042 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 11973338 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 1.31e-07 | 5 | 83 | 3 | 14758483 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 15365990 | ||
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 1.31e-07 | 5 | 83 | 3 | 12592609 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 19790048 | ||
| Pubmed | 1.33e-07 | 50 | 83 | 5 | 23658023 | ||
| Pubmed | 2.13e-07 | 22 | 83 | 4 | 27527664 | ||
| Pubmed | 2.18e-07 | 175 | 83 | 7 | 28071719 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 2.61e-07 | 6 | 83 | 3 | 17029294 | |
| Pubmed | The discoidin domain receptor tyrosine kinases are activated by collagen. | 2.61e-07 | 6 | 83 | 3 | 9659899 | |
| Pubmed | Development and regeneration of the neonatal digit tip in mice. | 2.61e-07 | 6 | 83 | 3 | 18234177 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 21467034 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 17135260 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 2.61e-07 | 6 | 83 | 3 | 8563024 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 7813775 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 16556917 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 2.61e-07 | 6 | 83 | 3 | 3571333 | |
| Pubmed | 3.09e-07 | 24 | 83 | 4 | 25344368 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 3.98e-07 | 62 | 83 | 5 | 28344315 | |
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 23273220 | ||
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 10072783 | ||
| Pubmed | 6.84e-07 | 29 | 83 | 4 | 34929174 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 7.28e-07 | 8 | 83 | 3 | 20059976 | |
| Pubmed | Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers. | 7.28e-07 | 8 | 83 | 3 | 23397623 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 27664939 | ||
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 7.28e-07 | 8 | 83 | 3 | 17510210 | |
| Pubmed | Type XIII collagen strongly affects bone formation in transgenic mice. | 7.28e-07 | 8 | 83 | 3 | 16007336 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 15872058 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 26553654 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 7.28e-07 | 8 | 83 | 3 | 24563484 | |
| Pubmed | In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. | 7.28e-07 | 8 | 83 | 3 | 22437311 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 7.28e-07 | 8 | 83 | 3 | 33875569 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 9164858 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 15781699 | ||
| Pubmed | Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia. | 1.03e-06 | 32 | 83 | 4 | 27770432 | |
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 1.09e-06 | 9 | 83 | 3 | 31844321 | |
| Pubmed | Microglia ablation alleviates myelin-associated catatonic signs in mice. | 1.09e-06 | 9 | 83 | 3 | 29252214 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 31199918 | ||
| Pubmed | FLNC IL16 ATP6V0A1 SBF1 NPEPPS PCLO DLG2 DLG4 RPS23 SCRIB MTHFS CBR1 PLP1 HNRNPK LUZP1 | 1.33e-06 | 1431 | 83 | 15 | 37142655 | |
| Pubmed | 1.43e-06 | 146 | 83 | 6 | 27068509 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 30738849 | ||
| Pubmed | Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. | 1.55e-06 | 10 | 83 | 3 | 15162503 | |
| Pubmed | Ucma is not necessary for normal development of the mouse skeleton. | 1.55e-06 | 10 | 83 | 3 | 22155508 | |
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 20864640 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 2446864 | ||
| Pubmed | VEGF stimulates intramembranous bone formation during craniofacial skeletal development. | 1.55e-06 | 10 | 83 | 3 | 26899202 | |
| Pubmed | Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. | 1.55e-06 | 10 | 83 | 3 | 16109715 | |
| Pubmed | 1.88e-06 | 153 | 83 | 6 | 25037231 | ||
| Pubmed | Hsp and chaperone distribution during endochondral bone development in mouse embryo. | 2.13e-06 | 11 | 83 | 3 | 9880236 | |
| Pubmed | The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. | 2.13e-06 | 11 | 83 | 3 | 20696843 | |
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 2745554 | ||
| Pubmed | Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. | 2.13e-06 | 11 | 83 | 3 | 15101818 | |
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 35988140 | ||
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 24248941 | ||
| Pubmed | 2.33e-06 | 39 | 83 | 4 | 30566624 | ||
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 2.33e-06 | 39 | 83 | 4 | 21606205 | |
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 32002646 | ||
| Pubmed | TPR NYAP2 SBF1 NPEPPS UBR4 DLG2 DLG4 SCRIB PLP1 HNRNPK LUZP1 KIF7 | 3.02e-06 | 963 | 83 | 12 | 28671696 | |
| Pubmed | 3.11e-06 | 167 | 83 | 6 | 22159717 | ||
| Pubmed | 3.51e-06 | 378 | 83 | 8 | 34315543 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 TPR FLNC SBF1 NPEPPS UBR4 RPS23 DDX43 SCRIB MTHFS SUCLG2 CBR1 HNRNPK LUZP1 | 3.65e-06 | 1353 | 83 | 14 | 29467282 |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 3.68e-06 | 13 | 83 | 3 | 11839810 | |
| Pubmed | 3.68e-06 | 13 | 83 | 3 | 31961823 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 3.68e-06 | 13 | 83 | 3 | 21173153 | |
| Interaction | MAG interactions | 5.60e-06 | 29 | 82 | 4 | int:MAG | |
| Interaction | SPARC interactions | 6.72e-06 | 65 | 82 | 5 | int:SPARC | |
| Interaction | PDGFA interactions | 8.39e-06 | 32 | 82 | 4 | int:PDGFA | |
| Interaction | DRP2 interactions | 1.05e-05 | 11 | 82 | 3 | int:DRP2 | |
| Interaction | COL1A2 interactions | 1.65e-05 | 78 | 82 | 5 | int:COL1A2 | |
| Interaction | TMEM44 interactions | 2.85e-05 | 15 | 82 | 3 | int:TMEM44 | |
| Interaction | DMWD interactions | 3.30e-05 | 90 | 82 | 5 | int:DMWD | |
| Interaction | FGF7 interactions | 3.50e-05 | 16 | 82 | 3 | int:FGF7 | |
| Interaction | LAIR2 interactions | 4.69e-05 | 49 | 82 | 4 | int:LAIR2 | |
| Interaction | GUCY1A2 interactions | 5.07e-05 | 18 | 82 | 3 | int:GUCY1A2 | |
| Interaction | KCNJ4 interactions | 7.04e-05 | 20 | 82 | 3 | int:KCNJ4 | |
| Cytoband | 17p13.1 | 1.31e-03 | 118 | 83 | 3 | 17p13.1 | |
| GeneFamily | Collagens | 7.09e-09 | 46 | 58 | 6 | 490 | |
| GeneFamily | PDZ domain containing | 5.43e-07 | 152 | 58 | 7 | 1220 | |
| GeneFamily | Dyneins, axonemal | 2.06e-05 | 17 | 58 | 3 | 536 | |
| GeneFamily | Arachidonate lipoxygenases | 1.50e-04 | 6 | 58 | 2 | 407 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.13e-04 | 206 | 58 | 5 | 682 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.03e-03 | 15 | 58 | 2 | 903 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.89e-03 | 25 | 58 | 2 | 504 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.13e-03 | 26 | 58 | 2 | 904 | |
| GeneFamily | Transient receptor potential cation channels | 3.62e-03 | 28 | 58 | 2 | 249 | |
| GeneFamily | Potassium voltage-gated channels | 7.30e-03 | 40 | 58 | 2 | 274 | |
| Coexpression | NABA_COLLAGENS | 4.66e-09 | 43 | 83 | 6 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 5.38e-09 | 44 | 83 | 6 | M3005 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 2.78e-07 | 44 | 83 | 5 | M18274 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.09e-06 | 29 | 83 | 4 | MM17055 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.54e-06 | 35 | 83 | 4 | MM17054 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 4.96e-06 | 137 | 83 | 6 | M40313 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 6.35e-06 | 82 | 83 | 5 | M39274 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 7.15e-06 | 146 | 83 | 6 | M40222 | |
| Coexpression | ZHU_CMV_24_HR_DN | 7.15e-06 | 84 | 83 | 5 | M4065 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.06e-05 | 91 | 83 | 5 | M40180 | |
| Coexpression | JONES_OVARY_THECA | 1.38e-05 | 46 | 83 | 4 | M48349 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.50e-05 | 47 | 83 | 4 | M7585 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_STROMAL_CELLS | 1.60e-05 | 99 | 83 | 5 | M40255 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.60e-05 | 99 | 83 | 5 | M39152 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 1.64e-05 | 48 | 83 | 4 | M39318 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.95e-05 | 261 | 83 | 7 | M1834 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 2.28e-05 | 179 | 83 | 6 | M41745 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.41e-05 | 18 | 83 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.41e-05 | 18 | 83 | 3 | M13796 | |
| Coexpression | NABA_CORE_MATRISOME | 2.43e-05 | 270 | 83 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.73e-05 | 275 | 83 | 7 | M5884 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 2.86e-05 | 19 | 83 | 3 | M15125 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.58e-05 | 117 | 83 | 5 | M39300 | |
| Coexpression | ZHU_CMV_ALL_DN | 3.88e-05 | 119 | 83 | 5 | M14555 | |
| Coexpression | GSE18148_CBFB_KO_VS_WT_TREG_DN | 4.24e-05 | 200 | 83 | 6 | M4252 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 4.25e-05 | 61 | 83 | 4 | M8510 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 5.14e-05 | 64 | 83 | 4 | M2572 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 5.46e-05 | 65 | 83 | 4 | M39309 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.91e-05 | 69 | 83 | 4 | M10165 | |
| Coexpression | DOANE_BREAST_CANCER_CLASSES_UP | 8.16e-05 | 72 | 83 | 4 | M17427 | |
| Coexpression | GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP | 8.41e-05 | 140 | 83 | 5 | M418 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 8.70e-05 | 141 | 83 | 5 | M10381 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 9.09e-05 | 74 | 83 | 4 | M4479 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 9.09e-05 | 74 | 83 | 4 | M13547 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.03e-04 | 146 | 83 | 5 | MM973 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 1.05e-04 | 29 | 83 | 3 | M7581 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.29e-04 | 81 | 83 | 4 | M39253 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.67e-04 | 162 | 83 | 5 | M45037 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 1.68e-04 | 257 | 83 | 6 | M13867 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.72e-04 | 369 | 83 | 7 | MM16610 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.86e-04 | 35 | 83 | 3 | M11788 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 1.94e-04 | 90 | 83 | 4 | M38984 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.03e-04 | 36 | 83 | 3 | MM1212 | |
| Coexpression | KAYO_CALORIE_RESTRICTION_MUSCLE_UP | 2.30e-04 | 94 | 83 | 4 | M7013 | |
| Coexpression | FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1 | 2.69e-04 | 98 | 83 | 4 | M41704 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 2.78e-04 | 40 | 83 | 3 | M1574 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 3.76e-04 | 107 | 83 | 4 | MM947 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 4.04e-04 | 109 | 83 | 4 | M2451 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 4.21e-04 | 46 | 83 | 3 | MM670 | |
| Coexpression | GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 4.41e-04 | 200 | 83 | 5 | M6212 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP | 4.41e-04 | 200 | 83 | 5 | M3834 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 4.61e-04 | 202 | 83 | 5 | M38982 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 5.08e-04 | 49 | 83 | 3 | M2899 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.39e-04 | 50 | 83 | 3 | M1259 | |
| Coexpression | DESCARTES_MAIN_FETAL_SCHWANN_CELLS | 5.71e-04 | 51 | 83 | 3 | M40070 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 6.05e-04 | 52 | 83 | 3 | MM1118 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.49e-05 | 97 | 81 | 5 | GSM777046_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 3.85e-05 | 99 | 81 | 5 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | COL2A1 TPR COL24A1 TRPM5 DNAH10 ZBTB4 DLG2 RPS23 MTHFS SUCLG2 LUZP1 COL1A1 COL1A2 | 7.93e-05 | 978 | 81 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | BM Top 100 - cervix | 1.18e-04 | 66 | 81 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_NA_vs_Mesoderm Day 5-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 1.33e-04 | 68 | 81 | 4 | PCBC_ratio_MESO-5_from-ESC_vs_MESO-5_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | BM Top 100 - ovary | 1.49e-04 | 70 | 81 | 4 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 1.75e-04 | 73 | 81 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.44e-04 | 229 | 81 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.72e-04 | 331 | 81 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.95e-04 | 445 | 81 | 8 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 3.15e-04 | 85 | 81 | 4 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.29e-04 | 86 | 81 | 4 | GSM777055_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.44e-04 | 87 | 81 | 4 | GSM777050_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | COL2A1 COL3A1 PRKD3 COL5A2 COL24A1 ALAS1 MTHFS COL1A1 COL1A2 | 4.04e-04 | 589 | 81 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL3A1 COL5A2 COL24A1 ALAS1 RPS23 MTHFS COL1A1 COL1A2 | 5.02e-04 | 607 | 81 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 5.20e-04 | 97 | 81 | 4 | GSM777043_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.22e-04 | 369 | 81 | 7 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL2A1 COL3A1 TPR COL24A1 ALAS1 RPS23 MTHFS LUZP1 COL1A1 COL1A2 | 5.22e-04 | 744 | 81 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.39e-04 | 371 | 81 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.79e-12 | 191 | 83 | 10 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.46e-11 | 189 | 83 | 9 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.46e-11 | 189 | 83 | 9 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.29e-11 | 191 | 83 | 9 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-10 | 196 | 83 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-10 | 196 | 83 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.28e-10 | 198 | 83 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-10 | 198 | 83 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.40e-10 | 200 | 83 | 9 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.40e-10 | 200 | 83 | 9 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-10 | 200 | 83 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-10 | 200 | 83 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-10 | 200 | 83 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.40e-10 | 200 | 83 | 9 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-09 | 180 | 83 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-09 | 182 | 83 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.87e-09 | 182 | 83 | 8 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-09 | 182 | 83 | 8 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-09 | 184 | 83 | 8 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 2.42e-09 | 188 | 83 | 8 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.63e-09 | 190 | 83 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.63e-09 | 190 | 83 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 2.85e-09 | 192 | 83 | 8 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.97e-09 | 193 | 83 | 8 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-09 | 194 | 83 | 8 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-09 | 195 | 83 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-09 | 195 | 83 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-09 | 195 | 83 | 8 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 3.35e-09 | 196 | 83 | 8 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-09 | 196 | 83 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-09 | 196 | 83 | 8 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-09 | 196 | 83 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-09 | 196 | 83 | 8 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-09 | 196 | 83 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 3.35e-09 | 196 | 83 | 8 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.49e-09 | 197 | 83 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.49e-09 | 197 | 83 | 8 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.63e-09 | 198 | 83 | 8 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-09 | 198 | 83 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.63e-09 | 198 | 83 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.78e-09 | 199 | 83 | 8 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-09 | 199 | 83 | 8 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 3.78e-09 | 199 | 83 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-09 | 199 | 83 | 8 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-09 | 199 | 83 | 8 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-09 | 199 | 83 | 8 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.78e-09 | 199 | 83 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.93e-09 | 200 | 83 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.93e-09 | 200 | 83 | 8 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.93e-09 | 200 | 83 | 8 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.93e-09 | 200 | 83 | 8 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.93e-09 | 200 | 83 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.93e-09 | 200 | 83 | 8 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.93e-09 | 200 | 83 | 8 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.93e-09 | 200 | 83 | 8 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-09 | 200 | 83 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-08 | 157 | 83 | 7 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-08 | 169 | 83 | 7 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-08 | 169 | 83 | 7 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-08 | 172 | 83 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-08 | 173 | 83 | 7 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-08 | 174 | 83 | 7 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-08 | 178 | 83 | 7 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-08 | 178 | 83 | 7 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-08 | 178 | 83 | 7 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.69e-08 | 180 | 83 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.69e-08 | 180 | 83 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-08 | 181 | 83 | 7 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-08 | 181 | 83 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-08 | 181 | 83 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-08 | 183 | 83 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-08 | 183 | 83 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-08 | 183 | 83 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-08 | 183 | 83 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.45e-08 | 184 | 83 | 7 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.66e-08 | 185 | 83 | 7 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.66e-08 | 185 | 83 | 7 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.66e-08 | 185 | 83 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-08 | 186 | 83 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.87e-08 | 186 | 83 | 7 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-08 | 186 | 83 | 7 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.09e-08 | 187 | 83 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.09e-08 | 187 | 83 | 7 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.55e-08 | 189 | 83 | 7 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-08 | 190 | 83 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.79e-08 | 190 | 83 | 7 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-08 | 191 | 83 | 7 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.04e-08 | 191 | 83 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-08 | 192 | 83 | 7 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.29e-08 | 192 | 83 | 7 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.29e-08 | 192 | 83 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.29e-08 | 192 | 83 | 7 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| Computational | Neighborhood of CDH11 | 4.49e-06 | 25 | 49 | 4 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 2.02e-05 | 36 | 49 | 4 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Placenta genes. | 2.08e-04 | 463 | 49 | 9 | MODULE_38 | |
| Computational | Signaling. | 5.83e-04 | 230 | 49 | 6 | MODULE_176 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | 9.20e-04 | 453 | 49 | 8 | MODULE_24 | |
| Computational | Genes in the cancer module 55. | COL2A1 COL3A1 COL5A2 DNAH3 ATP6V0A1 ETV3 ALAS1 MTHFS TNXB COL1A1 COL1A2 | 1.06e-03 | 832 | 49 | 11 | MODULE_55 |
| Computational | Genes in the cancer module 112. | 1.10e-03 | 260 | 49 | 6 | MODULE_112 | |
| Drug | Collagenase | 1.64e-10 | 4 | 83 | 4 | DB00048 | |
| Drug | malotilate | 7.28e-09 | 71 | 83 | 7 | CID000004006 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL3A1 PRKD3 PRKD2 COL24A1 ALOX12 ALOX15 COL1A1 COL1A2 | 3.00e-08 | 189 | 83 | 9 | CID000001413 |
| Drug | GK-101 | 1.97e-07 | 36 | 83 | 5 | CID000161853 | |
| Drug | ascorbate-2-phosphate | 2.17e-07 | 15 | 83 | 4 | ctd:C011669 | |
| Drug | strontium ranelate | 3.77e-07 | 77 | 83 | 6 | CID006918182 | |
| Drug | DMSe | 5.40e-07 | 132 | 83 | 7 | CID000020796 | |
| Drug | vitamin E | COL2A1 PRKD3 CKM TPR PRKD2 LIPI DCXR ALOX12 ALOX15 COL1A1 COL1A2 | 5.86e-07 | 441 | 83 | 11 | CID000002116 |
| Drug | Madecassol | 6.95e-07 | 46 | 83 | 5 | CID000108062 | |
| Drug | eicosa-8,11,14-trienoic acid | 8.34e-07 | 88 | 83 | 6 | CID000003011 | |
| Drug | BPAT-143 | 9.27e-07 | 6 | 83 | 3 | CID000146249 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 9.27e-07 | 6 | 83 | 3 | ctd:C502971 | |
| Drug | d-indobufen | 1.06e-06 | 50 | 83 | 5 | CID000044562 | |
| Drug | calcium phosphate | 1.22e-06 | 149 | 83 | 7 | CID000024441 | |
| Drug | ridogrel | 1.29e-06 | 52 | 83 | 5 | CID005362391 | |
| Drug | NSC49633 | 1.43e-06 | 53 | 83 | 5 | CID000023340 | |
| Drug | AC1L18QD | COL2A1 COL3A1 PRKD3 PRKD2 COL24A1 ALOX12 ALOX15 COL1A1 COL1A2 | 2.87e-06 | 325 | 83 | 9 | CID000000213 |
| Drug | AC1LAKND | 3.13e-06 | 62 | 83 | 5 | CID000470146 | |
| Drug | 4-hydroxymercuribenzoate | 3.86e-06 | 9 | 83 | 3 | ctd:C030601 | |
| Drug | BAPN | 6.14e-06 | 71 | 83 | 5 | CID000001647 | |
| Drug | isodesmosine | 6.20e-06 | 33 | 83 | 4 | CID000013811 | |
| Drug | cyanogen-bromide | 7.00e-06 | 34 | 83 | 4 | CID000010476 | |
| Drug | L-3,4-dehydroproline | 7.05e-06 | 73 | 83 | 5 | CID000094284 | |
| Drug | AC1NMZ1B | 8.05e-06 | 75 | 83 | 5 | CID005034185 | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 8.30e-06 | 199 | 83 | 7 | 7246_UP | |
| Drug | losartan | COL2A1 COL3A1 PRKD3 PRKD2 COL24A1 MMP21 ADCYAP1 COL1A1 COL1A2 | 9.70e-06 | 378 | 83 | 9 | CID000003961 |
| Drug | pirfenidone | 1.14e-05 | 138 | 83 | 6 | CID000040632 | |
| Drug | dioctanoyl-phosphatidylinositol 4,5-bisphosphate | 1.31e-05 | 2 | 83 | 2 | ctd:C112943 | |
| Drug | 5'-methylthioadenosine | 1.31e-05 | 2 | 83 | 2 | ctd:C008500 | |
| Drug | aldosterone | 1.43e-05 | 397 | 83 | 9 | CID000005839 | |
| Drug | halofuginone lactate | 1.49e-05 | 85 | 83 | 5 | CID000062891 | |
| Drug | AC1L1FO5 | 2.06e-05 | 15 | 83 | 3 | CID000003322 | |
| Drug | 4-hydroxyproline | 2.07e-05 | 91 | 83 | 5 | CID000000825 | |
| Drug | alizarin red S | 2.55e-05 | 95 | 83 | 5 | CID000008534 | |
| Drug | pamidronate | 3.07e-05 | 49 | 83 | 4 | CID000004673 | |
| Drug | prostacyclin sodium salt | 3.61e-05 | 250 | 83 | 7 | CID000000159 | |
| Drug | ticlopidine | 3.77e-05 | 103 | 83 | 5 | CID000005472 | |
| Drug | 13(R)-hydroxy-octadeca-(9Z,11E,15Z)-trienoic acid | 3.93e-05 | 3 | 83 | 2 | CID000643726 | |
| Drug | Wy-41,770 | 3.93e-05 | 3 | 83 | 2 | CID000165241 | |
| Drug | AC1L9DEH | COL2A1 COL3A1 PRKD3 PRKD2 SBF2 PLP1 ALOX12 ALOX15 COL1A1 COL1A2 | 4.16e-05 | 569 | 83 | 10 | CID000442783 |
| Drug | desmosine | 4.20e-05 | 53 | 83 | 4 | CID000025435 | |
| Drug | Ridauran | 4.86e-05 | 55 | 83 | 4 | CID006333887 | |
| Drug | hydroxylysine | 4.95e-05 | 109 | 83 | 5 | CID000001029 | |
| Drug | AC1L1DD6 | 4.96e-05 | 179 | 83 | 6 | CID000002299 | |
| Drug | 351A | 5.09e-05 | 20 | 83 | 3 | CID000122144 | |
| Drug | AC1L1C2F | 5.17e-05 | 110 | 83 | 5 | CID000001711 | |
| Drug | RHC 80267 | 5.63e-05 | 112 | 83 | 5 | CID000005063 | |
| Drug | PPACK | 5.88e-05 | 113 | 83 | 5 | CID003036757 | |
| Drug | MDL 27,032 | 5.93e-05 | 21 | 83 | 3 | CID000163812 | |
| Drug | proadifen hydrochloride | 6.13e-05 | 114 | 83 | 5 | CID000004910 | |
| Drug | AC1L9732 | 6.13e-05 | 114 | 83 | 5 | CID000439300 | |
| Drug | Tranilast sodium | 6.39e-05 | 115 | 83 | 5 | CID000005527 | |
| Drug | Alstonine hydrochloride | 6.66e-05 | 116 | 83 | 5 | CID000023039 | |
| Drug | 8-iso-prostaglandin E2 | COL2A1 PRKD3 PRKD2 IL16 RCCD1 CBR1 ALOX12 ADCYAP1 ALOX15 COL1A1 | 6.75e-05 | 603 | 83 | 10 | CID000000158 |
| Drug | foscarnet | 6.91e-05 | 190 | 83 | 6 | CID000003414 | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA | 7.12e-05 | 191 | 83 | 6 | 994_UP | |
| Drug | Frie Mao 1-43 | 7.31e-05 | 61 | 83 | 4 | CID002733618 | |
| Drug | protocatechuic acid | 7.52e-05 | 119 | 83 | 5 | CID000000072 | |
| Drug | rosiglitazone maleate; Down 200; 10uM; PC3; HG-U133A | 7.75e-05 | 194 | 83 | 6 | 430_DN | |
| Drug | colchine | 7.83e-05 | 383 | 83 | 8 | CID000002833 | |
| Drug | pentylhydrazine | 7.84e-05 | 4 | 83 | 2 | CID000014246 | |
| Drug | diacetylrhein | 7.84e-05 | 4 | 83 | 2 | ctd:C025292 | |
| Drug | T-22083 | 7.84e-05 | 4 | 83 | 2 | CID006439700 | |
| Drug | AC1NSP79 | 7.84e-05 | 4 | 83 | 2 | CID005313497 | |
| Drug | AC1NR0V5 | 7.84e-05 | 4 | 83 | 2 | CID005282813 | |
| Drug | BiM4 | 7.89e-05 | 283 | 83 | 7 | CID000002399 | |
| Drug | magnesium | COL2A1 PRKD3 CKM PRKD2 TRPM4 DNAH3 TKFC TRPM5 DNAH10 MMP21 MTHFS SUCLG2 DNAH9 COL1A1 COL1A2 | 7.94e-05 | 1325 | 83 | 15 | CID000000888 |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 3800_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2889_DN | |
| Drug | silibinin | 8.25e-05 | 285 | 83 | 7 | CID000005213 | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 3122_DN | |
| Drug | tyrphostin 25 | 8.46e-05 | 122 | 83 | 5 | CID000002061 | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 5635_UP | |
| Drug | Milrinone [78415-72-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 3552_UP | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 5857_UP | |
| Drug | AC1L3RSZ | 8.95e-05 | 24 | 83 | 3 | CID000094238 | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 9.17e-05 | 200 | 83 | 6 | 2912_UP | |
| Drug | Selara | 9.49e-05 | 125 | 83 | 5 | CID000150310 | |
| Drug | 4-aminoazobenzene | 9.96e-05 | 66 | 83 | 4 | CID000006051 | |
| Drug | POBN | 1.01e-04 | 25 | 83 | 3 | CID000092375 | |
| Drug | AC1L1H7H | 1.12e-04 | 68 | 83 | 4 | CID000004009 | |
| Drug | AC1L1DSW | 1.25e-04 | 70 | 83 | 4 | CID000002493 | |
| Drug | ONO-RS-082 | 1.25e-04 | 70 | 83 | 4 | CID006438389 | |
| Drug | 14-hydroxydocosahexaenoic acid | 1.30e-04 | 5 | 83 | 2 | CID006439735 | |
| Drug | N-(3-phenoxycinnamyl)acetohydroxamic acid | 1.30e-04 | 5 | 83 | 2 | ctd:C056614 | |
| Drug | artonin E | 1.30e-04 | 5 | 83 | 2 | CID005481962 | |
| Drug | Saralasin | 1.30e-04 | 5 | 83 | 2 | ctd:D012504 | |
| Drug | hydroxyoctadecadienoic acid | 1.30e-04 | 5 | 83 | 2 | ctd:C495366 | |
| Drug | AC1L2VAC | 1.30e-04 | 5 | 83 | 2 | CID000129261 | |
| Drug | DL-penicillamine | 1.56e-04 | 139 | 83 | 5 | CID000004727 | |
| Drug | PCR 4099 | 1.56e-04 | 139 | 83 | 5 | CID000002806 | |
| Drug | LS-63783 | COL2A1 COL3A1 PRKD3 PRKD2 COL24A1 TRPM5 SUCLG2 ALOX12 ALOX15 COL1A1 COL1A2 | 1.58e-04 | 804 | 83 | 11 | CID000000231 |
| Drug | flavanone | 1.73e-04 | 76 | 83 | 4 | CID000010251 | |
| Drug | calphostin C | 1.76e-04 | 431 | 83 | 8 | CID000002533 | |
| Drug | Griseofulvin | 1.81e-04 | 77 | 83 | 4 | ctd:D006118 | |
| Drug | candesartan cilexetil | 1.90e-04 | 145 | 83 | 5 | CID000002540 | |
| Drug | 6,9,12-octadecatrienoic acid | 1.91e-04 | 78 | 83 | 4 | CID000003453 | |
| Drug | 8-azaguanine | 1.91e-04 | 78 | 83 | 4 | CID000008646 | |
| Drug | AC1L571W | 1.95e-04 | 6 | 83 | 2 | CID000171201 | |
| Drug | colnelenic acid | 1.95e-04 | 6 | 83 | 2 | CID006441679 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 7.25e-09 | 9 | 83 | 4 | DOID:13359 (is_implicated_in) | |
| Disease | Ehlers-Danlos Syndrome | 2.14e-07 | 5 | 83 | 3 | C0013720 | |
| Disease | Ehlers-Danlos syndrome | 1.19e-06 | 8 | 83 | 3 | cv:C0013720 | |
| Disease | benign neoplasm (implicated_via_orthology) | 1.19e-06 | 8 | 83 | 3 | DOID:0060072 (implicated_via_orthology) | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 7.82e-06 | 2 | 83 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 7.82e-06 | 2 | 83 | 2 | C4551623 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 7.82e-06 | 2 | 83 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 7.82e-06 | 2 | 83 | 2 | cv:C0268362 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 7.82e-06 | 2 | 83 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 7.82e-06 | 2 | 83 | 2 | 259420 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 7.82e-06 | 2 | 83 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 7.82e-06 | 2 | 83 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 7.82e-06 | 2 | 83 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 7.82e-06 | 2 | 83 | 2 | 166220 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 7.82e-06 | 2 | 83 | 2 | 166210 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.53e-05 | 53 | 83 | 4 | C4707243 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 2.34e-05 | 3 | 83 | 2 | C4552122 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 2.34e-05 | 3 | 83 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 2.34e-05 | 3 | 83 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2.34e-05 | 3 | 83 | 2 | C0220679 | |
| Disease | OSTEOPOROSIS | 4.67e-05 | 4 | 83 | 2 | 166710 | |
| Disease | Left Ventricular Hypertrophy | 4.72e-05 | 25 | 83 | 3 | C0149721 | |
| Disease | Heart valve disease | 5.32e-05 | 26 | 83 | 3 | C0018824 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 7.77e-05 | 5 | 83 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 7.77e-05 | 5 | 83 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 7.77e-05 | 5 | 83 | 2 | C0023931 | |
| Disease | Osteoporosis | 1.16e-04 | 6 | 83 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 1.16e-04 | 6 | 83 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.63e-04 | 7 | 83 | 2 | C1846545 | |
| Disease | Bleeding tendency | 1.63e-04 | 7 | 83 | 2 | C1458140 | |
| Disease | Liver Cirrhosis | 2.08e-04 | 103 | 83 | 4 | C0023890 | |
| Disease | alcoholic hepatitis (is_marker_for) | 2.16e-04 | 8 | 83 | 2 | DOID:12351 (is_marker_for) | |
| Disease | Fibrosis, Liver | 2.24e-04 | 105 | 83 | 4 | C0239946 | |
| Disease | Cleft palate, isolated | 2.28e-04 | 42 | 83 | 3 | C1837218 | |
| Disease | Tumoral calcinosis | 2.28e-04 | 42 | 83 | 3 | C0263628 | |
| Disease | Calcinosis | 2.28e-04 | 42 | 83 | 3 | C0006663 | |
| Disease | Microcalcification | 2.28e-04 | 42 | 83 | 3 | C0521174 | |
| Disease | Early Pregnancy Loss | 2.59e-04 | 109 | 83 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 2.59e-04 | 109 | 83 | 4 | C0000786 | |
| Disease | Miscarriage | 2.59e-04 | 109 | 83 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 2.59e-04 | 109 | 83 | 4 | C0000822 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Situs ambiguous | 2.78e-04 | 9 | 83 | 2 | C1167664 | |
| Disease | Liver Cirrhosis, Experimental | 3.27e-04 | 774 | 83 | 9 | C0023893 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 3.47e-04 | 10 | 83 | 2 | C0268363 | |
| Disease | Fibrosis | 3.82e-04 | 50 | 83 | 3 | C0016059 | |
| Disease | Cirrhosis | 3.82e-04 | 50 | 83 | 3 | C1623038 | |
| Disease | Nephrosclerosis | 4.23e-04 | 11 | 83 | 2 | C0027719 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 4.23e-04 | 11 | 83 | 2 | C0268362 | |
| Disease | Aortic Valve Insufficiency | 4.23e-04 | 11 | 83 | 2 | C0003504 | |
| Disease | Situs Inversus | 4.23e-04 | 11 | 83 | 2 | C0037221 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 5.07e-04 | 12 | 83 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | breast carcinoma | PRKD2 COL5A2 NYAP2 NKD1 RCCD1 SBF2 SNTG1 ABCA8 COL1A1 COL1A2 | 5.73e-04 | 1019 | 83 | 10 | EFO_0000305 |
| Disease | Osteogenesis Imperfecta | 5.98e-04 | 13 | 83 | 2 | C0029434 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 5.98e-04 | 13 | 83 | 2 | cv:C4082197 | |
| Disease | adiponectin measurement | 7.81e-04 | 146 | 83 | 4 | EFO_0004502 | |
| Disease | carcinoma (implicated_via_orthology) | 7.90e-04 | 64 | 83 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Situs ambiguus | 8.02e-04 | 15 | 83 | 2 | C0266642 | |
| Disease | Schizophrenia | 8.40e-04 | 883 | 83 | 9 | C0036341 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 9.14e-04 | 16 | 83 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | Blood Coagulation Disorders | 9.14e-04 | 16 | 83 | 2 | C0005779 | |
| Disease | migraine without aura, susceptibility to, 4 | 9.14e-04 | 16 | 83 | 2 | MONDO_0011847 | |
| Disease | triacylglycerol 48:1 measurement | 1.03e-03 | 17 | 83 | 2 | EFO_0010404 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.11e-03 | 276 | 83 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | Oral Submucous Fibrosis | 1.16e-03 | 18 | 83 | 2 | C0029172 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 1.30e-03 | 19 | 83 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | triglyceride measurement, body mass index | 1.30e-03 | 19 | 83 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | brain volume measurement | 1.45e-03 | 595 | 83 | 7 | EFO_0006930 | |
| Disease | QRS duration | 1.55e-03 | 298 | 83 | 5 | EFO_0005055 | |
| Disease | Cleft Palate | 1.56e-03 | 81 | 83 | 3 | C0008925 | |
| Disease | triglyceride measurement, body fat percentage | 1.59e-03 | 21 | 83 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Osteogenesis imperfecta | 1.59e-03 | 21 | 83 | 2 | cv:C0029434 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.98e-03 | 315 | 83 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | complement C4b measurement | 2.25e-03 | 25 | 83 | 2 | EFO_0008092 | |
| Disease | body fat percentage, high density lipoprotein cholesterol measurement | 2.25e-03 | 25 | 83 | 2 | EFO_0004612, EFO_0007800 | |
| Disease | Bipolar Disorder | 2.29e-03 | 477 | 83 | 6 | C0005586 | |
| Disease | response to antineoplastic agent | 2.77e-03 | 99 | 83 | 3 | GO_0097327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALKLGGSARGHNGVR | 131 | Q86Y79 | |
| RGGAGHKAKRVTGGR | 266 | Q66K41 | |
| HKAKRVTGGRGGRQG | 271 | Q66K41 | |
| SGERVEGKVLGFGHG | 11 | Q86SG2 | |
| GTQGRHAGGLGKEFS | 101 | Q08345 | |
| SRNAIGGGGIGHQKR | 211 | P41162 | |
| TNIHGRGGGALLGDR | 481 | P00736 | |
| VRGTSAHFGIQLRGG | 111 | Q9NRI5 | |
| GHEQKGLTGAVGGVI | 1876 | Q2TAZ0 | |
| TLTGGFRRGKLQGHD | 316 | Q9NP87 | |
| ERGLKGHRGFTGLQG | 1126 | P02458 | |
| AQGKSVGVGHVARGA | 351 | Q969G9 | |
| LAGVFGSRGLKHGGV | 56 | Q8NI28 | |
| KAGGVGLNLIGGSHL | 721 | Q9Y620 | |
| GFGQELGSGRGRQVH | 16 | A6NED2 | |
| GLGFDKHGNRLGRGK | 136 | P49914 | |
| KQHGAGAGGTRNISG | 271 | P13196 | |
| GTLLLRSGGFHGKGV | 1191 | Q86WG5 | |
| RSGGFHGKGVVGLFK | 1196 | Q86WG5 | |
| GRKLGISGQAFGVGA | 276 | Q9BRR8 | |
| HTVSGNGLGIRIVGG | 4506 | Q9Y6V0 | |
| GGGTRARHVIINVGG | 11 | Q9UJ96 | |
| GAAVDIKLGFGRGRH | 221 | Q8N119 | |
| GKGIGRGTVQALHAT | 16 | Q7Z4W1 | |
| EGGAHKVRAGGTGLE | 2311 | Q14315 | |
| GKHEEGRFSGLLGRG | 876 | Q14005 | |
| LGGVNAVGHSRGGEK | 1211 | Q2M1P5 | |
| VLGSGQFGVVYGGKH | 556 | Q9BZL6 | |
| VLGSGQFGIVYGGKH | 581 | O94806 | |
| GGGGHVQLLKQAGAF | 421 | P16050 | |
| LGDQGGKEFGHLGKV | 326 | Q96KK3 | |
| KAVSTGGGGHVQLLR | 416 | P18054 | |
| AIKRIGGEVGRGHEG | 71 | Q9P242 | |
| VLLRSGGLHGKGVVG | 1206 | O95248 | |
| GGLHGKGVVGLFKAQ | 1211 | O95248 | |
| AGKHLQSLVARGVGG | 101 | P18509 | |
| FKGIRGHNGLDGLKG | 176 | P08123 | |
| DKGHLLLVGIGGSGR | 2426 | Q8TD57 | |
| VVRGGRVNTHAGGTG | 226 | Q9GZV9 | |
| FAGGKLIFGGRVLNG | 786 | Q8ND61 | |
| RGDRGQKGHRGFTGL | 1136 | P05997 | |
| HVALVTGGNKGIGLA | 6 | P16152 | |
| IHRGSTGLGFNIVGG | 316 | P78352 | |
| ETVFGKRGHVLGNGS | 536 | Q86V48 | |
| RGVRIGGISGIFKSH | 116 | Q9UK59 | |
| ETGERGAAGIKGHRG | 1096 | P02461 | |
| KGLGFSIAGGVGNQH | 201 | Q15700 | |
| GGAGTGKSQVLRSLH | 2151 | Q9NYC9 | |
| RGHALLVGVGGSGKQ | 2796 | Q8IVF4 | |
| RGQGHFLGIVGGSSA | 266 | Q9H4Q3 | |
| RFSILGHSFGGVVGG | 101 | Q9H4I8 | |
| SVIGGVAGGSKHGRK | 811 | P55786 | |
| SHFVGAVIGRGGSKI | 76 | Q9NXZ2 | |
| EFKVGIIGGGHLGKQ | 76 | Q6NXP6 | |
| IIGGGHLGKQLAGTL | 81 | Q6NXP6 | |
| GGKAPGQHGGFVVTV | 16 | Q9P0W2 | |
| RFSILGHSFGGVVGG | 101 | Q9NQF3 | |
| GSGVPRAGKQGQHAV | 1046 | Q9NZ71 | |
| AHGRHKGSGRTGGLV | 271 | Q9Y3M8 | |
| QFVKHGGGLLIGGQA | 141 | A6NFQ2 | |
| NLGTGLRGGVHVKLA | 286 | P06732 | |
| GFVGKIFHGQLGRIT | 166 | Q6XZB0 | |
| GGFGLSIKGGAEHNI | 66 | Q9NSN8 | |
| LHIIKRGDGTGGVTG | 121 | Q00889 | |
| IHQSLAGGIIGVKGA | 151 | P61978 | |
| IAALGGAGGKGNRFF | 181 | Q9H4K7 | |
| VGGLGLSIKGGSEHN | 81 | Q9NY99 | |
| LGISIRGGARGHAGN | 1111 | Q14160 | |
| GEVLGLLGHNGAGKS | 1316 | O94911 | |
| EQGDRGIKGHRGFSG | 1101 | P02452 | |
| HGLIGKTGNPGERGF | 956 | Q17RW2 | |
| GGQVGTETLVTHGKG | 361 | Q9Y3P4 | |
| LVAGFGRKGHAVGDI | 101 | P62266 | |
| ILAGGRGKGVFNSGL | 86 | Q96I99 | |
| RGKGVFNSGLKGGVH | 91 | Q96I99 | |
| LKGVIGFGGHGTRQA | 361 | Q96KV7 | |
| LGLHRGEVNFGGSGK | 21 | Q9NZQ8 | |
| LVGKGGFGTVFRAQH | 26 | Q9Y572 | |
| GVSHAMGGRGGINRG | 2346 | P12270 | |
| FHGGQRVGPVSAIGV | 3131 | P22105 | |
| GFRGGPEHVVKVVGG | 291 | Q9P1Z0 | |
| VLGSQRIGLHGSGGL | 331 | Q4ZJI4 | |
| KHLGTLNFGGIRVGN | 666 | Q93050 | |
| AARLLQLGHKGGGVV | 231 | O60346 | |
| QLGHKGGGVVKVLGQ | 236 | O60346 | |
| KGRVALLSGGGSGHE | 46 | Q3LXA3 | |
| GPGKGHQGFGVLSVI | 461 | Q5T4S7 | |
| GGLHTGIGRHVGVAV | 156 | Q8TD43 | |
| TVTGGQKGRGSRGQH | 116 | P60201 |